VERSES AI Halted, Cash at $68,000, and a 90-Day Rescue Clock Starts
28.06.2026 - 05:44:49 | boerse-global.de
Once a high-flying artificial intelligence name trading above C$24 on the Cboe Canada exchange, VERSES AI has descended into a crisis that few retail holders ever imagined. The Canadian exchange suspended trading in both the company’s common shares and warrants at the close on June 19, triggering a 90-day review period during which VERSES must prove it still meets listing requirements. By the time the bell rang, the stock had already slumped 43% in five sessions to C$0.38, giving the company a market capitalisation of roughly C$3.74 million.
The financial figures behind that slide are brutal. VERSES ended its latest fiscal year with approximately $68,000 in cash on hand — against total liabilities of nearly $2 million. A net loss of roughly $43 million for fiscal 2026 followed a $52 million loss the prior year. Revenue over the trailing twelve months amounted to just $155,000, and the gross margin stood at negative 307%. Management has blamed the collapse on “extreme liquidity constraints” and failed capital raises that prevented the transition from research to commercialisation.
Those cash constraints have decimated the executive suite. Chief scientist Karl Friston, whose work on active inference formed the theoretical backbone of the “Genius” platform, resigned, severely denting the credibility of the company’s remaining intellectual property. President and COO James Hendrickson, CTO Hari Thiruvengada, and the chief science officer all departed as well, reportedly amid clashes with the board over unpaid salaries. Founder and former CEO Gabriel René stepped down in February, followed by CFO Kevin Wilson and brand ambassador Dan Mapes. Interim CEO David T. Scott, in the role since February, is now reviewing “strategic alternatives” with little room to manoeuvre.
Should investors sell immediately? Or is it worth buying VERSES AI?
Efforts to keep the business alive have all fallen short. A licensing agreement with Prodigii AI signed in April 2026 — promising an initial $350,000 payment plus quarterly $125,000 installments over ten years — became void when the board decided to halt all AI activities. Separate discussions with an unnamed global investment house also ended. In January the company cut roughly half its workforce and asked senior staff to defer parts of their salaries. A March capital raise priced at C$0.75 per unit managed to pull in only about C$746,000, far too small to stabilise operations.
Now the clock is ticking. The 90-day review by Cboe Canada will determine whether VERSES can resume trading. Meanwhile, the company is due to file its next quarterly report on July 6, which is expected to provide audited figures on remaining assets and an update on the strategic review. The only meaningful asset left is the “Genius” patent portfolio, but without an active AI business its value is highly uncertain. VERSES has warned explicitly that there is no guarantee the strategic process will yield a transaction that ensures survival.
Shareholders are in a limbo where they can neither buy nor sell their holdings. If no buyer emerges for the intellectual property, or if a rescue financing fails to materialise, the company faces full liquidation. For a firm that once promised to pioneer a new paradigm in artificial intelligence, the countdown has become brutally simple: find a deal within 90 days, or disappear.
Ad
VERSES AI Stock: New Analysis - 28 June
Fresh VERSES AI information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
